Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 5/20 | 0.78 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.78 |
| ▸ | LMNA | P02545 | 3/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.78 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.78 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.78 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.78 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.78 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.78 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.78 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.78 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.78 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.78 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.76 |
| ▸ | VDR | P11473 | 2/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.76 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18576000 | 1.00 | GPBAR1 (0.78) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL19313991 | 1.00 | GPBAR1 (0.78) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL18844053 | 1.00 | GPBAR1 (0.78) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL14544659 | 1.00 | GPBAR1 (0.78) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL21752770 | 1.00 | GPBAR1 (0.78) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL24151937 | 1.00 | GPBAR1 (0.78) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL16892648 | 1.00 | GPBAR1 (0.78) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL28266346 | 0.94 | GPBAR1 (0.72) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL8965370 | 0.92 | GPBAR1 (0.78) | GPBAR1EPHA2LMNAHSD17B10TDP1 | |
| SCHEMBL27513055 | 0.91 | GPBAR1 (0.77) | GPBAR1EPHA2LMNAHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119930728-A | Efficient synthesis method of 3-oxo-4, 22-diene cholanic acid-24 methyl ester | 浙江工业大学 | 2025-05-06 | — | — | CN | claimed |
| CN-104398504-A | Deoxypodophyllotoxin medicine-containing pharmaceutical composition and preparation method and preparation thereof | Zhejiang jianfeng pharmaceutical co ltd | 2015-03-11 | — | — | CN | claimed |
| CN-119930728-A | Efficient synthesis method of 3-oxo-4, 22-diene cholanic acid-24 methyl ester | 浙江工业大学 | 2025-05-06 | — | — | CN | disclosed |
| CN-119930728-A | Efficient synthesis method of 3-oxo-4, 22-diene cholanic acid-24 methyl ester | 浙江工业大学 | 2025-05-06 | — | — | CN | disclosed |
| CN-119930728-A | Efficient synthesis method of 3-oxo-4, 22-diene cholanic acid-24 methyl ester | 浙江工业大学 | 2025-05-06 | — | — | CN | disclosed |
| CN-119684165-A | Cholesteric molecular clamp artificial receptor and method for detecting zinc ions in food by using same | 青海大学 | 2025-03-25 | — | — | CN | disclosed |
| CN-118994287-A | Preparation method of alpha-rat bile acid intermediate | 浙江工业大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-113264972-B | Method for preparing obeticholic acid | 四川科伦药物研究院有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-113330020-B | 2-fluoro bile acids for the treatment of neurodegenerative diseases | NZP英国有限公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2023227723-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ARAMCHOL AND SALTS THEREOF | PHARMAZELL GMBH (DE) | 2023-11-30 | — | — | WO | disclosed |
| US-11617804-B2 | Hyaluronic acid-based nanoparticles as biosensors for imaging-guided surgery and drug delivery vehicles and methods associated therewith | WAKE FOREST UNIVERSITY (US) | 2023-04-04 | — | — | US | disclosed |
| CN-106008639-A | Cholanic acid compounds for preventing or treating FXR-mediated diseases | 深圳市塔吉瑞生物医药有限公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-104853758-A | Treatment of pulmonary disease | INTERCEPT PHARMACEUTICALS INC | 2015-08-19 | — | — | CN | disclosed |
| CN-104398504-A | Deoxypodophyllotoxin medicine-containing pharmaceutical composition and preparation method and preparation thereof | Zhejiang jianfeng pharmaceutical co ltd | 2015-03-11 | — | — | CN | disclosed |
| EP-1966228-B1 | PURIFICATION PROCESS FOR CHENODEOXYCHOLIC ACID | DAEWOONG BIO INC (KR) | 2015-01-21 | — | — | EP | disclosed |
| EP-1960416-B1 | PURIFICATION PROCESS FOR CHENODEOXYCHOLIC ACID | DAE WOONG PHARMA (KR) | 2014-12-31 | — | — | EP | disclosed |
| CN-103143027-A | Preparation of hyaluronic-acid-based double-targeting nano-composite medicament and application of double-targeting nano-composite medicament | UNIV XIAMEN | 2013-06-12 | — | — | CN | disclosed |
| US-20120309700-A1 | DEVELOPMENT AND EVALUATION OF NOVEL CHINESE MATERIA MEDICA PREPARATIONS | SONG CHING (CN) | 2012-12-06 | — | — | US | disclosed |
| CN-101497641-A | Method for synthesizing delta 24(28) cholesterol compounds | THIRD MILTARY MEDICAL UNIVERSI (CN) | 2009-08-05 | — | — | CN | disclosed |
| WO-2004037275-A1 | BILE ACID CONJUGATES AND PARTICLES FORMED THEREWITH | WIELAND, HEINRICH (DE) | 2004-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11617804-B2 | Hyaluronic acid-based nanoparticles as biosensors for imaging-guided surgery and drug delivery vehicles and methods associated therewith | CD44, HLA-A, HLA-C | GPBAR1 349/4885EPHA2 47/4885LMNA 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.